Eli Lilly is returning its development and commercialization rights to Transition Therapeutics’ TT401 after opting not to advance the diabetes candidate into Phase III development. Transition, which ...
On July 24, 2023, the National Academies of Sciences, Engineering, and Medicine convened a one-day public workshop to examine challenges and opportunities for a just transition and sustainable ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min While the application process ...
Goodbye New START: How China’s Rise Ended Nuclear Arms Control After pledging to stop funding coal-powered power plants last year, the ADB is developing a framework to speed up the region’s green ...
Remains in the LDC category and is entitled to receive all benefits available to LDCs Prepares a national transition strategy and establishes a consultative mechanism to facilitate its preparation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results